The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
Spanios a company known for its unique D tumoroid platforms used to validate solid tumor therapies has announced a new partnership with Accelerated Biosciences Accelerated Biosciences
A Biotherapeutics Inc has initiated the Phase clinical trial for AB marking a significant milestone in the development of its innovative cell therapy This clinicalstage company specializes
Aulos Bioscience a company in immunooncology striving to transform cancer treatment with innovative IL therapeutics has announced a significant collaboration with Ares Trading SA a Swiss subsidiary
FogPharma and ARTBIO Inc are collaborating to develop advanced therapies for various cancers FogPharma renowned for its innovative Helicon peptide platform and ARTBIO
Verismo Therapeutics has received approval from the US Food and Drug Administration to proceed with the Phase clinical trial of SynKIR for NHL This trial named CELESTIAL will evaluate the safety
Ajax Therapeutics Inc a biopharmaceutical company focused on developing nextgeneration JAK inhibitors for patients with myeloproliferative neoplasms has announced the clearance
TriLink BioTechnologies a division of Maravai LifeSciences and a leading global provider of life science reagents and services has announced a collaboration with Johns Hopkins University to accelerate
Walden Biosciences Inc a biotechnology company focused on developing therapies for kidney disease has partnered with the Primula Group to utilize genetic data from individuals with chronic kidney disease
Macomics Ltd a leader in macrophage drug discovery has announced a significant scientific collaboration with Prof Massimiliano Pagani from IFOM the AIRC Institute of Molecular Oncology
Dyno Therapeutics has recently announced an exciting collaboration with NVIDIA aimed at leveraging Dynos cuttingedge artificial intelligence and in vivo experimentation prowess alongside NVIDIAs
